*  Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) - Full Text View -...
Tranquilizing Agents. Central Nervous System Depressants. Psychotropic Drugs. Dopamine Antagonists. Dopamine Agents. ... Serotonin Agents. Neurotransmitter Agents. Molecular Mechanisms of Pharmacological Action. Physiological Effects of Drugs. ...
  https://clinicaltrials.gov/ct2/show/NCT01172652?term=anxiety&rank=5
*  Intensive Motivational Interviewing for Methamphetamine Dependence - Full Text View - ClinicalTrials.gov
Autonomic Agents. Peripheral Nervous System Agents. Dopamine Agents. Neurotransmitter Agents. Molecular Mechanisms of ... Adrenergic Agents. Adrenergic Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Dopamine ...
  https://clinicaltrials.gov/ct2/show/NCT01071356?recr=Open&cond=%22Methamphetamine%22&rank=17
*  An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention...
Dopamine Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Molecular Mechanisms of ...
  https://clinicaltrials.gov/show/NCT00249353
*  Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults - Full Text View - ClinicalTrials.gov
Dopamine Agents. Neurotransmitter Agents. Physiological Effects of Drugs. Cytochrome P-450 CYP2D6 Inhibitors. Cytochrome P-450 ... Antidepressive Agents, Second-Generation. Antidepressive Agents. Psychotropic Drugs. Dopamine Uptake Inhibitors. ...
  https://clinicaltrials.gov/ct2/show/NCT01270555
*  Glutamate, Brain Connectivity and Duration of Untreated Psychosis - Full Text View - ClinicalTrials.gov
Tranquilizing Agents. Central Nervous System Depressants. Psychotropic Drugs. Dopamine Antagonists. Dopamine Agents. ... Serotonin Agents. Neurotransmitter Agents. Molecular Mechanisms of Pharmacological Action. Physiological Effects of Drugs. ... Genes related to glutamate, n-acetyl-aspartate, dopamine, schizophrenia, and treatment response to antipsychotic medication ...
  https://clinicaltrials.gov/ct2/show/NCT02034253?recr=Open&cond=%22Psychotic+Disorders%22&rank=7
*  Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion Paradigm - Full Text View - ClinicalTrials.gov
Autonomic Agents. Peripheral Nervous System Agents. Dopamine Agents. Neurotransmitter Agents. Molecular Mechanisms of ... A research study designed to examine amphetamine-induced dopamine release using the PET imaging agent [11C]PHNO in tobacco ... Adrenergic Agents. Adrenergic Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Dopamine ... Dopamine release will be measured as a percent change in binding potential. Increased dopamine release will result in decreased ...
  https://clinicaltrials.gov/ct2/show/NCT01699607?recr=Open&cond=amphetamine+
*  Staccato Prochlorperazine Single Dose PK - Full Text View - ClinicalTrials.gov
Tranquilizing Agents. Central Nervous System Depressants. Psychotropic Drugs. Dopamine Antagonists. Dopamine Agents. ... Autonomic Agents. Peripheral Nervous System Agents. Physiological Effects of Drugs. Gastrointestinal Agents. Antipsychotic ...
  https://clinicaltrials.gov/show/NCT00610727
*  Emotional Effects of Methylphenidate and MDMA in Healthy Subjects - Full Text View - ClinicalTrials.gov
Dopamine Agents. Neurotransmitter Agents. Hallucinogens. Psychotropic Drugs. Serotonin Agents. Adrenergic Uptake Inhibitors. ... Dopamine Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Molecular Mechanisms of ... MDMA releases serotonin (5-HT), dopamine (DA), and norepinephrine (NE). 5-HT release mainly contributes to the subjective ... a dopamine (DA) and norepinephrine (NE) transporter blocker, in healthy subjects. The primary goal is to determine the role of ...
  https://clinicaltrials.gov/ct2/show/NCT01465685
*  Transdermal Methylphenidate for Cancer-Related Fatigue - Full Text View - ClinicalTrials.gov
Dopamine Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Molecular Mechanisms of ...
  https://clinicaltrials.gov/show/NCT01124500
*  Striatal Dopamine Transporter Density in Post-Traumatic Stress Disorder (PTSD) - Full Text View - ClinicalTrials.gov
Dopamine. Dopamine Agents. Cardiotonic Agents. Sympathomimetics. Autonomic Agents. Peripheral Nervous System Agents. ... There have been studies that have shown a protein in blood called dopamine transporter (DAT) moves dopamine from one place to ... Striatal Dopamine Transporter Density in Post-Traumatic Stress Disorder (PTSD). The safety and scientific validity of this ... Dopamine is a substance found in our brains that has a role in regulating fear and stress as well as other emotional responses ...
  https://clinicaltrials.gov/ct2/show/NCT03216434?term=Traumatic+Brain+Injury&
*  Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD) - Full Text View - ClinicalTrials.gov
Serotonin Agents. Neurotransmitter Agents. Molecular Mechanisms of Pharmacological Action. Dopamine D2 Receptor Antagonists. ... Antipsychotic Agents. Tranquilizing Agents. Central Nervous System Depressants. Physiological Effects of Drugs. Psychotropic ...
  https://clinicaltrials.gov/ct2/show/NCT00766064
*  Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea - Full Text View -...
Tranquilizing Agents. Central Nervous System Depressants. Psychotropic Drugs. Dopamine Antagonists. Dopamine Agents. ... Hypoglycemic Agents. Physiological Effects of Drugs. Serotonin Antagonists. Serotonin Agents. Neurotransmitter Agents. ...
  https://clinicaltrials.gov/ct2/show/NCT01423487?term=Amenorrhea%3A+Clinical+Trials&rank=4
*  Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder. - Full Text View -...
At randomization subjects must have received therapeutic dosages of approved SSRI or SNRI agents for at least 8 weeks, with the ... Dopamine Uptake Inhibitors. Neurotransmitter Uptake Inhibitors. Membrane Transport Modulators. Molecular Mechanisms of ... any antipsychotic agent; any mood stabilizer; any standing benzodiazepine regimen other than at low doses for sleep (≤ 1 mg ... lorazepam HS or the equivalent); or a standing regimen of any other agent that may affect cognitive function (e.g., ...
  https://clinicaltrials.gov/ct2/show/NCT01148979?term=Alexander+Disease&rank=4
*  Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders - Full Text View -...
Tranquilizing Agents. Central Nervous System Depressants. Psychotropic Drugs. Dopamine Antagonists. Dopamine Agents. ... Serotonin Agents. Neurotransmitter Agents. Molecular Mechanisms of Pharmacological Action. Physiological Effects of Drugs. ...
  https://clinicaltrials.gov/ct2/show/NCT00221403
*  Bruxism - Wikipedia
... dopamine agents, antidepressants, muscle relaxants, and others. However, there is little, if any, evidence for their respective ... Examples may include dopamine agonists, dopamine antagonists, tricyclic antidepressants, selective serotonin reuptake ... Nicotine stimulates release of dopamine, which is postulated to explain why bruxism is twice as common in smokers compared to ... Evidence for this comes from observations of the modifying effect of medications which alter dopamine release on bruxing ...
  https://en.wikipedia.org/wiki/Bruxism
*  Extrapyramidal symptoms - Wikipedia
Another common course of treatment includes dopamine agonist agents such as pramipexole. These medications reverse the symptoms ... Extrapyramidal symptoms are most commonly caused by typical antipsychotic drugs that antagonize dopamine D2 receptors. The most ... Commonly used medications for EPS are anticholinergic agents such as benztropine (Cogentin), diphenhydramine (Benadryl), and ... and norepinephrine-dopamine reuptake inhibitors (NDRI) have also resulted in EPS. Specifically, duloxetine, sertraline, ...
  https://en.wikipedia.org/wiki/Extrapyramidal_symptoms
*  6-APB - Wikipedia
... it is a serotonin-norepinephrine-dopamine releasing agent (SNDRA). In addition to actions at the monoamine transporters, 6-APB ... In addition, 6-APB not only blocks the reuptake of these monoamine neurotransmitters but is also a releasing agent of them; ... 6-APB and its structural isomer 5-APB have been tested with a series of agents including: Marquis, Liebermann, Mecke, and ... 6-APB is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) with Ki values of 117, 150, and 2698 nM for the ...
  https://en.wikipedia.org/wiki/6-APB
*  List of antidepressants - Wikipedia
... serotonin-norepinephrine-dopamine releasing agent (SNDRA), and weak RIMA Etryptamine [α-Ethyltryptamine (αET)] (Monase) - non- ... may act as a norepinephrine-dopamine releasing agent (NDRA) alternatively or additionally; also a non-competitive antagonist of ... Rampello, Liborio; Nicoletti, Ferdinando; Nicoletti, Francesco (2000). "Dopamine and Depression". CNS Drugs. 13 (1): 35-45. doi ... weak serotonin-dopamine reuptake inhibitor (SDRI) and 5-HT2A and 5-HT2C receptor antagonist Oxaflozane (Conflictan) - 5-HT1A, 5 ...
  https://en.wikipedia.org/wiki/List_of_antidepressants
*  Ocotea cymbarum - Wikipedia
Pharmacologically, MDMA acts as a serotonin-norepinephrine-dopamine releasing agent and reuptake inhibitor.[citation needed] ...
  https://en.wikipedia.org/wiki/Ocotea_cymbarum
*  3,4-Methylenedioxy-N-ethylamphetamine - Wikipedia
MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor. Possession of MDEA is illegal in ...
  https://en.wikipedia.org/wiki/3,4-Methylenedioxy-N-ethylamphetamine
*  Norepinephrine-dopamine reuptake inhibitor - Wikipedia
A closely related type of drug is a norepinephrine-dopamine releasing agent (NDRA). Norepinephrine-dopamine reuptake inhibitors ... A norepinephrine-dopamine reuptake inhibitor (NDRI) is a drug that acts as a reuptake inhibitor for the neurotransmitters ... Monoamine reuptake inhibitor Dopamine reuptake inhibitor Norepinephrine reuptake inhibitor Stephen M. Stahl (2 March 2009). ... This in turn leads to increased extracellular concentrations of both norepinephrine and dopamine and, therefore, an increase in ...
  https://en.wikipedia.org/wiki/Norepinephrine%E2%80%93dopamine_reuptake_inhibitor
*  Cathine - Wikipedia
Like amphetamines, cathinone, and ephedrine, cathine acts as a norepinephrine releasing agent (NRA). It also acts as a dopamine ... releasing agent (DRA) to a lesser extent. Cathine is one of the four stereoisomers of phenylpropanolamine (PPA). The World Anti ...
  https://en.wikipedia.org/wiki/Cathine
*  List of MeSH codes (D16) - Wikipedia
... dopamine agents MeSH D27.505.519.625.150.151 --- dopamine agonists MeSH D27.505.519.625.150.175 --- dopamine antagonists MeSH ... dopamine agents MeSH D27.505.696.577.150.151 --- dopamine agonists MeSH D27.505.696.577.150.175 --- dopamine antagonists MeSH ... anti-allergic agents MeSH D27.505.954.122 --- anti-infective agents MeSH D27.505.954.122.085 --- anti-bacterial agents MeSH ... antiviral agents MeSH D27.505.954.122.388.077 --- anti-retroviral agents MeSH D27.505.954.122.388.077.088 --- anti-hiv agents ...
  https://en.wikipedia.org/wiki/List_of_MeSH_codes_(D16)
*  Spasmodic torticollis - Wikipedia
In the past, dopamine blocking agents have been used in the treatment of spasmodic torticollis. Treatment was based on the ... It has also been suggested that the functional imbalance is due to an imbalance of neurotransmitters such as dopamine, ... Relief from spasmodic torticollis is higher in those patients who take anticholinergic agents when compared to other oral ... of patients who use anticholinergic agents report relief, 21% of patients report relief from clonazepam, 11% of patients report ...
  https://en.wikipedia.org/wiki/Spasmodic_torticollis
*  Phenylpropanolamine - Wikipedia
PPA acts primarily as a selective norepinephrine releasing agent. It also acts as a dopamine releasing agent with around 10- ... Dopamine-β-hydroxylase catalyzed the removal of the pro-R hydrogen atom and the production of 1-norephedrine, (2S,1R)-2-amino-1 ... Agents such as metaraminol exhibit a greater degree of indirect sympathomimetic activity. Substitution on the β-Carbon Atom ... The metabolism of p-OHA to p-OHNor is well documented and dopamine-β hydroxylase present in noradrenergic neurons could easily ...
  https://en.wikipedia.org/wiki/Phenylpropanolamine